Orchid BioSciences Pockets $20M in Stock Offering | GenomeWeb

NEW YORK, Feb. 27 - Orchid BioSciences on Wednesday said it has pocketed approximately $20 million in a special stock offering announced last week.

Orchid said it sold 8 million shares of common stock that were offered through a prospectus supplement  in-line with the company's shelf-registration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.